The drug sulthiame reduces the number of breathing pauses and improves sleep quality in patients with obstructive sleep apnea, according to a European clinical study in which the University of ...

Researchers have found a link between more severe sleep apnea and one particular environmental issue in cities. Here we ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of moderate to severe sleep apnea certain patients with obesity. Photo courtesy ...

Even mild obstructive sleep apnea can cause disruptive symptoms, such as brain fog and fatigue, which may benefit from treatment. Treatment for mild OSA can include CPAP therapy, an oral appliance, ...

For the first time, researchers have shown that tackling obstructive sleep apnea’s two root causes at once, using both oxygen ...

At World Sleep 2025, a multicenter French study followed 253 adults with moderate to severe obstructive sleep apnea (OSA) ...

The American Academy of Sleep Medicine has indicated that an estimated 26 percent of adults between the ages of 30 and 70 years have sleep apnea. (Photo: Getty) You could say that it’s difficult to ...

Please provide your email address to receive an email when new articles are posted on . Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD.

Please provide your email address to receive an email when new articles are posted on . Researchers found heightened odds for mortality among veterans with no sleep apnea vs. with mild to moderate ...

Men with HIV and severe sleep-disordered breathing experience the greatest sleep disruption, with lower efficiency, more light sleep, and unstable sleep stages.

New mothers are more likely to experience severe pain that disrupts sleep and activities of daily living, as well as develop ...

The drug sulthiame reduces the number of breathing pauses and improves sleep quality in patients with obstructive sleep apnea ...